American Century Companies’s Oric Pharmaceuticals ORIC Stock Holding History

American Century Companies's ORIC Position: Q2 2026 in Review

American Century Companies increased its Oric Pharmaceuticals (ORIC) stake by 15% in Q2 2026, buying an estimated $198K and bringing the position to 168,628 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

American Century Companies first reported a position in ORIC in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.86M in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

• American Century Companies held 168,628 shares of Oric Pharmaceuticals worth $1.83M as of Q2 2026.
• American Century Companies bought 21,824 Oric Pharmaceuticals shares in Q2 2026, an estimated $198K.
• Oric Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2226 holding.
• American Century Companies first reported a position in Oric Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
• American Century Companies's Oric Pharmaceuticals position peaked at $1.86M in Q1 2026.
• 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.